Cantor Equity Partners IV, Inc. (CEPF): Cash & Equivalents

Annual figures by period end, from SEC filings.

$25.0K

As of 2025-12-31

Period ended	Cash & Equivalents	Change YoY	Source filing
2025-12-31	$25.0K	n/a	2026-03-26, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Blank Checks), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Cash & Equivalents	Change YoY
Cantor Equity Partners IV, Inc. (CEPF)	2025-12-31	$25.0K	n/a
Bain Capital GSS Investment Corp. (BCSS)	2025-12-31	$0	n/a
EQV Ventures Acquisition Corp. II (EVAC)	2025-12-31	$1.09M	n/a
Drugs Made In America Acquisition II Corp. (DMII)	2025-12-31	$223	n/a
American Exceptionalism Acquisition Corp. A (AEXA)	2025-12-31	$0	n/a
Innventure, Inc. (INV)	2025-12-31	$60.45M	+443.7%
Apex Treasury Corp (APXT)	2025-12-31	$991.5K	n/a
Berto Acquisition Corp. (TACO)	2025-12-31	$0	n/a
Velos Acquisition I Corp. (VLOS)	2025-12-31	$0	n/a

Compare CEPF, BCSS, EVAC, DMII side by side · Screen every company in Blank Checks ↗